
Sign up to save your podcasts
Or


Editor Helen Frankish discusses highlights from the June issue: a randomised trial showing the efficacy of a ketogenic diet to protect against childhood epilepsy; and a trial with phase II results for the Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease.
By The Lancet NeurologyEditor Helen Frankish discusses highlights from the June issue: a randomised trial showing the efficacy of a ketogenic diet to protect against childhood epilepsy; and a trial with phase II results for the Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease.

43,687 Listeners

299 Listeners

503 Listeners

53 Listeners

113,121 Listeners

94 Listeners

518 Listeners

189 Listeners

59 Listeners

80 Listeners

0 Listeners